Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 7, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Berkeley Lights (“Berkeley Lights” or the “Company”) (NASDAQ: BLI) common stock between July 17, 2020 and September 14, 2021, inclusive (the “Class Period”).

If you suffered a loss on your Berkeley Lights investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/berkeley-lights-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On September 15, 2021, Scorpion Capital published a research report, alleging, among other things, that Berkeley Lights’ customers “allege they were ‘tricked,’ misled, or over-promised into buying a $2 million lemon” and that the Company’s “product claims and practices may constitute outright fraud.” Citing interviews with former employees and executives, the report stated that Berkeley Lights is “a chaotic, wayward company that never found a viable product, value proposition, or market – and corroborate the scathing feedback from customers.” Other problems mentioned in the Scorpion Capital report included the fact that the Company’s instruments were not robust enough for commercial use and frequently broke down, were prone to contamination, suffered from throughput limitations, were plagued by data integrity issues, and experienced repeated software problems.

On this news, Berkeley Lights’ stock fell $9.23, or 28%, over two trading days to close at $23.53 per share on September 16, 2021, thereby injuring investors.

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Berkeley Lights’ flagship instrument, the Beacon, suffered from numerous design and manufacturing defects including breakdowns, high error rates, data integrity issues and other problems, limiting the ability of biotechnology companies and research institutions to consistently use the machines at scale; (2) that Berkeley Lights had received numerous customer complaints regarding the durability and effectiveness of the Company’s automation systems, including complaints related to the design and manufacturing detailed above, and described herein; (3) that the actual market for Berkeley Lights’ products and services was a fraction of the $23 billion represented to investors because of, inter alia, the relatively high cost of the Company’s instruments and consumables and inability to provide the sustained performance necessary to justify these high costs; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Berkeley Lights common stock during the Class Period, you may move the Court no later than February 7, 2022 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211215005199/en/